
In 2020, the Nobel Prize in Chemistry was awarded to Emmanuelle Charpentier and Jennifer Doudna for the development of a precision-based gene-editing technology with multiple applications ranging from medicine to agriculture.
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR-Cas) enables scientists to target precise spots in the DNA and introduce small mutations that ultimately modify the features of the organism.